Earnshaw S, Carlsen J, McDade C, Le Coent V, Sable B, Dassaud J. Costs and outcomes associated with large volume delayed sampling and pathogen reduction technology processing given an updated reimbursement approach. Presented at the AABB Virtual 2021 Annual Meeting; October 17, 2021.
Peloquin F, Breton MC, Wasserman M, Wilson M, McDade C, Farkouh R. Pneumococcal vaccination provides substantial value for money for Canadians. Presented at the IDWeek 2017 Conference; October 6, 2017. San Diego, CA.
Wasserman M, Wilson M, McDade C, Grajales AG, Palacios MG, Baez- Revueltas FB, Farkouh R. Estimating the clinical and economic impact of maintaining use of 13-valent Pneumococcal Conjugate Vaccine (PCV13) in Mexico. Presented at the IDWeek 2017 Conference; October 6, 2017. San Diego, CA.
Wasserman M, Rejas J, Mendez C, Wilson M, McDade C, Moffatt M, Farkouh R. Estimating clinical and economic impact of switching from the 13-valent (PCV13) to the 10-valent (PCV10) Pneumococcal Conjugate Vaccine in Spain. Presented at the 35th Annual Meeting of the European Society for Paediatric Infectious Diseases; May 24, 2017. Madrid, Spain.
Earnshaw SR, Chirila C, McDade CL, Black L, Andriole GL. Cost-effectiveness of dutasteride as a chemoprevention in prostate cancer: rEDUCE within-trial analysis. Presented at the 2011 ISPOR 16th Annual International Meeting; May 2011.